322 related articles for article (PubMed ID: 22112368)
1. Differential regional expression patterns of α-synuclein, TNF-α, and IL-1β; and variable status of dopaminergic neurotoxicity in mouse brain after Paraquat treatment.
Mitra S; Chakrabarti N; Bhattacharyya A
J Neuroinflammation; 2011 Nov; 8():163. PubMed ID: 22112368
[TBL] [Abstract][Full Text] [Related]
2. The influence of preconditioning with low dose of LPS on paraquat-induced neurotoxicity, microglia activation and expression of α-synuclein and synphilin-1 in the dopaminergic system.
Kuter KZ; Śmiałowska M; Ossowska K
Pharmacol Rep; 2022 Feb; 74(1):67-83. PubMed ID: 34762280
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
[TBL] [Abstract][Full Text] [Related]
4. PACAP deficiency sensitizes nigrostriatal dopaminergic neurons to paraquat-induced damage and modulates central and peripheral inflammatory activation in mice.
Watson MB; Nobuta H; Abad C; Lee SK; Bala N; Zhu C; Richter F; Chesselet MF; Waschek JA
Neuroscience; 2013 Jun; 240():277-86. PubMed ID: 23500093
[TBL] [Abstract][Full Text] [Related]
5. Dietary administration of paraquat for 13 weeks does not result in a loss of dopaminergic neurons in the substantia nigra of C57BL/6J mice.
Minnema DJ; Travis KZ; Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck MJ; Mathews JM; Tisdel MO; Cook AR; Botham PA; Smith LL
Regul Toxicol Pharmacol; 2014 Mar; 68(2):250-8. PubMed ID: 24389362
[TBL] [Abstract][Full Text] [Related]
6. Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat.
McCormack AL; Thiruchelvam M; Manning-Bog AB; Thiffault C; Langston JW; Cory-Slechta DA; Di Monte DA
Neurobiol Dis; 2002 Jul; 10(2):119-27. PubMed ID: 12127150
[TBL] [Abstract][Full Text] [Related]
7. Blockade of Rapid Influx of Extracellular Zn
Tamano H; Morioka H; Nishio R; Takeuchi A; Takeda A
Mol Neurobiol; 2019 Jun; 56(6):4539-4548. PubMed ID: 30341553
[TBL] [Abstract][Full Text] [Related]
8. [Protective effects of taurine on neurons and microglia in Parkinson's disease-like mouse model induced by paraquat].
Tian T; Zhang BY; Wang KD; Zhang BF; Huang M
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2020 Nov; 38(11):801-808. PubMed ID: 33287470
[No Abstract] [Full Text] [Related]
9. A time-course study of microglial activation and dopaminergic neuron loss in the substantia nigra of mice with paraquat-induced Parkinson's disease.
Yang HM; Wang YL; Liu CY; Zhou YT; Zhang XF
Food Chem Toxicol; 2022 Jun; 164():113018. PubMed ID: 35430334
[TBL] [Abstract][Full Text] [Related]
10. Paraquat induces alternation of the dopamine catabolic pathways and glutathione levels in the substantia nigra of mice.
Kang MJ; Gil SJ; Koh HC
Toxicol Lett; 2009 Jul; 188(2):148-52. PubMed ID: 19446248
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia.
Bai L; Zhang X; Li X; Liu N; Lou F; Ma H; Luo X; Ren Y
Mol Med Rep; 2015 Jul; 12(1):1002-8. PubMed ID: 25777539
[TBL] [Abstract][Full Text] [Related]
12. Manganese induces dopaminergic neurodegeneration via microglial activation in a rat model of manganism.
Zhao F; Cai T; Liu M; Zheng G; Luo W; Chen J
Toxicol Sci; 2009 Jan; 107(1):156-64. PubMed ID: 18836210
[TBL] [Abstract][Full Text] [Related]
13. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
[TBL] [Abstract][Full Text] [Related]
14. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
15. Paraquat-induced inflammatory response of microglia through HSP60/TLR4 signaling.
Sun Y; Zheng J; Xu Y; Zhang X
Hum Exp Toxicol; 2018 Nov; 37(11):1161-1168. PubMed ID: 29441825
[TBL] [Abstract][Full Text] [Related]
16. Naringenin alleviates paraquat-induced dopaminergic neuronal loss in SH-SY5Y cells and a rat model of Parkinson's disease.
Ahmad MH; Fatima M; Ali M; Rizvi MA; Mondal AC
Neuropharmacology; 2021 Dec; 201():108831. PubMed ID: 34655599
[TBL] [Abstract][Full Text] [Related]
17. Genetic dissection of strain dependent paraquat-induced neurodegeneration in the substantia nigra pars compacta.
Jiao Y; Lu L; Williams RW; Smeyne RJ
PLoS One; 2012; 7(1):e29447. PubMed ID: 22291891
[TBL] [Abstract][Full Text] [Related]
18. Minocycline inhibition of microglial rescues nigrostriatal dopaminergic neurodegeneration caused by mutant alpha-synuclein overexpression.
Wang Y; Wang Q; Yu R; Zhang Q; Zhang Z; Li H; Ren C; Yang R; Niu H
Aging (Albany NY); 2020 Jul; 12(14):14232-14243. PubMed ID: 32706757
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and B-cell Lymphoma-2 Associated X Protein Regulate Zinc-Induced Apoptotic Degeneration of Rat Nigrostriatal Dopaminergic Neurons.
Chauhan AK; Mittra N; Kumar V; Patel DK; Singh C
Mol Neurobiol; 2016 Oct; 53(8):5782-95. PubMed ID: 26497033
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory lncRNA AK039862 regulates paraquat-inhibited proliferation and migration of microglial and neuronal cells through the Pafah1b1/Foxa1 pathway in co-culture environments.
Zhang Y; Shao W; Wu J; Huang S; Yang H; Luo Z; Zheng F; Wang YL; Cai P; Guo Z; Wu S; Li H
Ecotoxicol Environ Saf; 2021 Jan; 208():111424. PubMed ID: 33120262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
